ABM Raises EPS Guidance, Waterdrop Revenue Surges 72.8%, GE Aerospace Lands $11.75 Billion Deal

Mumbai, Sept 8 : Corporate developments remained active as companies reported mixed earnings, raised forecasts, announced acquisitions and unveiled strategic deals. ABM Industries posted higher revenue and earnings, Berkshire Hathaway’s operating profit climbed 16.3%, while Waterdrop’s revenue surged 72.8%. GE Aerospace also agreed to acquire CPP for $11.75 billion, highlighting continued dealmaking activity. 

ABM Delivers Record Revenue and Raises Full-Year Adjusted EPS Guidance to $3.95-$4.10 

ABM (NYSE: ABM) reported fiscal third quarter revenue of $2.3 billion, up 4.2% year-over-year, with organic growth of 2.1% and acquisition-related growth of 2.1%. Net income increased 19% to $49.7 million ($0.84 per diluted share) from $41.8 million ($0.67) in the prior year, while adjusted net income grew 19% to $61.5 million ($1.04 per share). Adjusted EBITDA improved 11% to $139.6 million, and nine-month free cash flow surged to $199.6 million from $42.4 million in the prior year period.  

The company raised the midpoint of its full-year adjusted EPS outlook to $3.95-$4.10 and increased free cash flow expectations to approximately $210 million. Aviation and Manufacturing & Distribution led revenue growth with 12% and 18% increases respectively, while Business & Industry declined 2.6% as expected.  

The company secured a $300 million trade receivables facility and reduced its leverage ratio to 2.9x. Shares traded at $49.55, up 5.31% or $2.50, reaching a high of $49.55 and low of $45.77. 

UNFI Beats Q4 EPS Estimates by 13.1% as Free Cash Flow Hits Record $323 Million 

United Natural Foods (NYSE: UNFI) reported fourth-quarter adjusted earnings per share of $0.69, surpassing Wall Street estimates of $0.61 by 13.1%, though revenue of $7.64 billion came in slightly below the $7.69 billion forecast. Gross margin improved 30 basis points to 13.7%, while adjusted EBITDA reached $172 million.  

For the full fiscal year 2026, sales totalled $31.2 billion with adjusted EBITDA climbing 27% to $701 million and adjusted EPS of $2.65 above the high end of guidance. Free cash flow reached a record $323 million, and net leverage improved to 2.2 times, down 1.1 turns from a year earlier. The company’s natural products business saw sales rise about 7% with EBITDA up 19%, while the conventional segment posted EBITDA growth of more than 50%.  

Management guided fiscal 2027 adjusted EBITDA of $730 million to $780 million and adjusted EPS of $3.00 to $3.50, and authorised a new $200 million share repurchase programme. Shares rose 1.66% in premarket trading to $44.66. 

Canaan Reports $97.6 Million Net Loss as Bitcoin Price Pressures Trigger $25.3 Million Inventory Write-Down 

Canaan Inc. (NASDAQ: CAN) reported second-quarter total revenue of $31.9 million, down from $62.7 million in the first quarter and $100.2 million a year earlier, as product revenue fell to $13.6 million and mining revenue declined to $17.7 million amid lower bitcoin prices and seasonal curtailments.  

The company recorded a gross loss of $29.3 million, including a $25.3 million inventory write-down, prepayment write-down and provision for inventory purchase commitments, a $9.2 million impairment of property and equipment, and an $18.2 million loss from fair value change in cryptocurrency. Net loss widened to $97.6 million from $88.7 million in the previous quarter. Despite challenges, the company’s digital asset treasury reached a record 1,915 BTC and 3,952 ETH, and it repurchased 16.4 million ADSs for $7.4 million under its share repurchase programme.  

Management expects third-quarter revenue of $11 million to $15 million, reflecting near-term market conditions. Shares traded at $0.32, down 10.03% or $0.036, with a high of $0.35 and low of $0.32. 

Berkshire Hathaway Operating Earnings Rise 16.3% to $13 Billion as Market Capitalisation Stays Above $1 Trillion 

Berkshire Hathaway (NYSE: BRK.B) reported second-quarter operating earnings of $13 billion, up 16.3% year-over-year, after revenue rose 10% to $101.8 billion. Pretax earnings increased 13.9% while costs and expenses rose 8.4% to $86 billion. Insurance underwriting earnings fell 13.1% to $1.7 billion, but railroad operating revenues climbed 14.6% to $6.6 billion.  

The Insurance and Other segment generated $88.5 billion in revenue, while Manufacturing, Service and Retailing revenue rose 15.2% to $61.5 billion. Consolidated shareholders’ equity stood at $750.2 billion, up 4.2% from December 2025, though cash and equivalents declined 59.1% year-over-year to $41.4 billion.  

Market capitalisation remained above $1 trillion at $1.1 trillion, with shares trading at $506.98, up 0.19% from the previous close. 

Also Read: How to invest in US stocks

Gamehaus Revenue Declines 20.8% to $24.3 Million as Net Income Falls 38.2% Amid Strategic Transition 

Gamehaus Holdings (NASDAQ: GMHS) reported fourth-quarter fiscal 2026 revenue of $24.3 million, a 20.8% decrease from $30.7 million in the same period last year, driven by a strategic reduction in user acquisition spending and adjustments to marketing approaches. Operating costs fell 14.4% to $25.1 million, while net income declined 38.2% to $0.9 million from $1.5 million.  

For the full fiscal year, revenue was $104.7 million, down 11.4% from $118.0 million, though net income increased marginally by 0.8% to $3.9 million. Selling and marketing expenses decreased 13.6% in the quarter to $10.2 million, while research and development expenses remained stable at $1.5 million.  

The company extended its share repurchase programme for an additional year and expects first-quarter fiscal 2027 revenue of $20 million to $23 million as it transitions resources toward AI-generated content initiatives. Shares traded at $0.81, up 0.65% or $0.0053, with a high of $0.83 and low of $0.72. 

Waterdrop Revenue Surges 72.8% to RMB1.45 Billion as Insurance Business Drives 18th Consecutive Profitable Quarter 

Waterdrop Inc. (NYSE: WDH) reported second-quarter operating revenue of RMB1,448.2 million ($1.45 billion), a 72.8% year-over-year increase, with net profit attributable to ordinary shareholders reaching RMB125.8 million, marking 18 consecutive quarters of profitability. Insurance-related revenue grew 80.5%, while insurance business operating profit rose 20% quarter-over-quarter to RMB183.6 million. Premiums facilitated by the ‘AI Medical Insurance Expert’ rose 25.6% sequentially, and first-year premiums for long-term insurance grew 33.4%.  

The company launched ‘Rongyibao’, the market’s first long-term critical illness insurance product requiring no health disclosure with five-year guaranteed renewability. Waterdrop Medical Crowdfunding has seen 499 million donors contribute RMB74.7 billion to 3.82 million patients since its launch. The E-Find Platform generated RMB35.2 million in quarterly revenue, partnering with 255 pharma companies.  

The company has cumulatively repurchased approximately 62.9 million ADSs as of 31 August 2026. Shares traded at $1.06, up 3.92% or $0.040, with a high of $1.15 and low of $1.02. 

IRSA Posts Record Rental EBITDA of $200 Million as Net Income Jumps 61% to ARS420.9 Billion 

IRSA (NYSE: IRS) reported fiscal 2026 net income of ARS420.9 billion, up 61% from ARS261.9 billion in the prior year, with rental adjusted EBITDA reaching a record $200 million—the highest level since 2013. Shopping mall occupancy remained steady at 97%, while office occupancy was 100%.  

Tenant sales in malls fell 8.5% in real terms, but rental revenue still rose 1.5% thanks to inflation-linked contracts. The company benefited from a positive change in the fair value of investment properties of ARS193.7 billion compared with a negative result a year earlier. Cash position stood at $390 million with gross debt of about $620 million, resulting in a net debt-to-EBITDA ratio of 1.4 times.  

Management expects fiscal 2027 to be a peak CapEx year at approximately $150 million, funded by existing cash and operating cash flow without tapping capital markets. The company is advancing major projects including Distrito Diagonal, Al Oeste Shopping, and Ramblas del Plata. Shares traded at $15.07, down 0.59% from the previous close. 

GE Aerospace to Acquire CPP for $11.75 Billion to Expand Mission-Critical Castings Capacity 

GE Aerospace (NYSE: GE) has signed a definitive agreement to acquire Consolidated Precision Products (“CPP”), a leading manufacturer of highly engineered castings, from private investment firms Warburg Pincus and Berkshire Partners for $11.75 billion. The transaction will be financed with $7 billion in cash, with the remainder in new debt, and values CPP at approximately 18x 2027 EBITDA including expected net synergies, or approximately 26x without synergies.  

The acquisition is expected to be accretive to adjusted EPS and free cash flow in the first year, with no change to GE Aerospace’s capital allocation plans. CPP, headquartered in Cleveland, Ohio, employs approximately 6,600 people across more than 20 facilities globally and is one of the world’s largest producers of investment and precision sand castings. GE Aerospace has been a CPP customer for over fifteen years.  

The transaction is expected to close in the second half of 2027, subject to regulatory approvals and other customary closing conditions. GE Aerospace’s Brazilian depositary receipts traded at 86.02 BRL, down 0.91% or 0.79 BRL, with a high of 86.84 BRL and low of 85.58 BRL. 

EverBank and WaFd Announce $3.9 Billion Reverse Merger Creating $75 Billion Regional Bank 

Florida-based EverBank Financial has agreed to acquire WaFd, a smaller bank in the Pacific Northwest, in a $3.9 billion reverse merger transaction. Under the deal, EverBank will merge into WaFd, with the latter remaining a publicly traded company after changing its name to EverBank Financial Corp and trading under the new ticker symbol EVBK on the Nasdaq. Upon completion, EverBank investors will collectively own approximately 59.2% of the pro forma combined company, with WaFd shareholders owning the remaining 40.8%.  

The merger, expected to close in early 2027, is projected to increase WaFd’s 2027 earnings per share by roughly 29% and recoup tangible book value dilution in less than two years. The combined entity will have approximately $75 billion in assets, creating a regional banking presence spanning from Florida to the Pacific Northwest. EverBank’s ADRs traded at $25.58, unchanged from the previous close, with a day range of $25.52 to $25.70. 

Circle to Acquire Tazapay for Undisclosed Sum to Accelerate USDC Distribution at Scale 

Circle Internet Group (NYSE: CRCL), the global financial technology firm and issuer of USDC, has signed a definitive agreement to acquire Tazapay, a Singapore-headquartered B2B cross-border payments infrastructure company. Tazapay brings over $25 billion of annualised payment volume, 60+ banking and fintech partners, and local payout rails covering over 100 markets. Approximately 60% of Tazapay’s transaction volume already includes stablecoins.  

The acquisition will accelerate Circle’s mission to build the infrastructure layer for global digital finance, expanding its capability to originate and terminate payments globally near-instant and 24/7. The deal is expected to close in 2027, subject to customary closing conditions and regulatory approvals, including approval from the Monetary Authority of Singapore. Tazapay has been a design partner for Circle Payments Network since 2025. Circle shares traded at $96.48, down 5.46% or $5.58, with a high of $100.80 and low of $96.37. 

Labcorp Acquires MLM Medical Labs to Expand Central Laboratory Network Across Four Continents 

Labcorp (NYSE: LH) has announced the acquisition of MLM Medical Labs, a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed. The acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents: North America, Europe, Asia and Africa.  

MLM operates the continent’s first fully CAP-accredited central laboratory in Africa, enhancing Labcorp’s ability to support complex multinational clinical trials with consistent scientific, operational and regulatory oversight. The transaction also strengthens Labcorp’s scientific and regulatory expertise and broadens access to biomarker and specialty testing capabilities that support increasingly complex clinical development programmes. Evercore served as exclusive financial advisor to Labcorp, with Pierson Ferdinand and Hogan Lovells serving as legal counsel. Labcorp shares traded at $326.89, unchanged from the previous close, with a high of $326.90 and low of $318.67. 

Also Read: US Stock Market Timings

Qualcomm Surges 9.5% on Amazon AI Deal and 25 Million Share Warrant 

Qualcomm Technologies (NASDAQ: QCOM) shares surged 9.5% following the announcement of a multi-generational collaboration with Amazon to build customised silicon and ultra-fast optical connectivity solutions for AI data centres.  

Under the agreement, Qualcomm will issue a warrant to Amazon to purchase up to 25 million shares of QCOM common stock, signalling deep, long-term alignment between the two companies. The partnership centres on heavy-duty AI inference workloads and optical connectivity solutions extending up to 1.6T and future-generation solutions.  

Qualcomm will work directly with Amazon Web Services (“AWS”) to design and deliver energy-efficient, customised silicon tailored for massive AI data centres, pairing AWS’s comprehensive AI infrastructure with Qualcomm’s leadership in power-efficient processing. The companies are also co-developing high-speed optical connectivity solutions built on Qualcomm’s advanced SerDes and optical DSP technologies. As part of the expanded collaboration, Qualcomm plans to deepen its use of AWS AI infrastructure, including Amazon Bedrock, for electronic design automation workloads, targeting a reduction in chip design cycles. Qualcomm shares traded at an intraday high, reflecting strong investor response to the collaboration announcement. 

Palantir and Nebius Partner to Deliver Sovereign AI Infrastructure for Commercial Customers 

Palantir Technologies (NASDAQ: PLTR) and Nebius Group (NASDAQ: NBIS) have entered into a strategic partnership to integrate Nebius’s cloud and artificial intelligence computing infrastructure with Palantir’s enterprise platform for commercial customers. Palantir has selected Nebius as its preferred sovereign AI infrastructure partner, with the companies aiming to give eligible customers greater control over computing resources, data and models used to run AI applications.  

Following an integration period, Nebius compute resources and inference endpoints are expected to become available within the Palantir enterprise perimeter. Customers will be able to deploy open models using Nebius infrastructure and adapt those models with their own proprietary information for specific applications.  

The companies also intend to accelerate the deployment of new computing capacity through modular data-centre installations at locations where power infrastructure is already available. Palantir shares traded at $171.80, down 1.45% or $2.53, while Nebius shares rose 9.64%. 

Verizon and Corning Sign Multi-Billion-Dollar Fiber Supply Agreement for Broadband and AI Infrastructure 

Verizon Communications and Corning Incorporated have reached a multi-billion-dollar agreement for over 80 million miles of high-density optical fibre and connectivity solutions from 2027 to 2032. The multi-use fibre deployment will accelerate broadband expansion for homes and businesses while building the national long-haul backbone required by AI hyperscalers. The agreement secures supply chain certainty for Verizon’s push toward 40-50 million broadband passings and deepens its 30-year strategic partnership with Corning.  

Corning will continue to scale its US manufacturing footprint to ensure Verizon has the physical materials needed to execute its convergence strategy and expand its long-haul AI corridors, including Corning Contour Flow Cable which enables significantly more optical fibre deployment within conduit pathways. Corning shares surged over 8% intraday to $165.70, while Verizon shares rose modestly by approximately 1% to $50.51. 

Holtec Nuclear Launches IPO Roadshow Targeting Up to $18 Per Share 

Holtec Nuclear Corporation has launched a roadshow for its proposed initial public offering of 50,000,000 shares of Class A common stock, with the initial public offering price expected to be between $15.00 and $18.00 per share. The company plans to grant underwriters a 30-day option to purchase up to an additional 7,500,000 shares of Class A common stock to cover over-allotments.  

Holtec intends to list its Class A common stock on the Nasdaq Global Select Stock Market and Nasdaq Texas, Inc. under the ticker symbol NASDAQ: HNUC. J.P. Morgan, Guggenheim Securities, Goldman Sachs & Co. LLC, Citigroup, and BofA Securities are acting as joint book-running managers and representatives of the underwriters, with Morgan Stanley, Cantor, BMO Capital Markets, and Oppenheimer & Co. also acting as joint book-running managers. A registration statement on Form S-1 has been filed with the US Securities and Exchange Commission but has not yet become effective. 

Robinhood Enters IPO Underwriting with Oura Listing, Marking First Official Underwriting Role 

Robinhood Markets (NASDAQ: HOOD) is expanding beyond retail brokerage by joining the underwriting syndicate for smart-ring maker Oura’s planned IPO, marking its first official IPO underwriting role. Oura’s SEC filing lists Robinhood Securities among 18 underwriters. Through IPO Access, the company has historically depended on investment banks to allocate it a limited number of IPO shares for distribution to customers.  

An official role in the underwriting process could give Robinhood greater influence over retail allocations, potentially helping it secure more shares for its users. The Robinhood Ventures Fund I also holds Oura, pointing to an existing relationship with the company. HOOD shares have jumped 45.7% over the past three months compared with the industry’s growth of 10.8%, though the company appears near the bottom of Oura’s underwriting syndicate, suggesting its initial economics and influence may be modest. HOOD shares declined 0.98%, while Charles Schwab fell 0.81% and Interactive Brokers declined 0.74%. 

American Savings Bank Launches IPO Roadshow Targeting $15-$17 Per Share 

American Savings Bank, N.A. (“ASB”) has launched the roadshow for its initial public offering of 7,496,436 shares of its common stock to be sold by certain existing stockholders. The initial public offering price is expected to be between $15.00 and $17.00 per share.  

The selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,126,632 shares to cover over-allotments. ASB has applied to list its common stock on the New York Stock Exchange under the symbol ”ASBH.”  

Piper Sandler & Co. is acting as the sole book-running manager, with Keefe, Bruyette & Woods acting as lead manager, while D.A. Davidson & Co. and Stephens Inc. are acting as co-managers. A registration statement has been filed with the Office of the Comptroller of the Currency but has not yet become effective. 

United Therapeutics Accelerates $477.6 Million Share Repurchase Under $2 Billion Authorisation 

United Therapeutics Corporation (NASDAQ: UTHR) has announced it will utilise the remainder of its previously announced $2 billion share repurchase authorisation through an Accelerated Share Repurchase (“ASR”) agreement with Citibank, N.A. for approximately $477.6 million.  

The company previously entered into ASR agreements to repurchase an aggregate $1.5 billion of its common stock in March 2026 and purchased an additional $22.4 million in open-market transactions during the third quarter of 2026. Under the ASR agreement, United Therapeutics will make an aggregate upfront payment of approximately $477.6 million and receive an initial delivery of shares representing approximately 75% of the total shares anticipated to be repurchased based on the closing stock price on September 8, 2026.  

The final number of shares will be based on the average daily volume-weighted average price per share during the term, less a discount and subject to adjustments. Upon completion, the company will have returned $4 billion to shareholders in approximately 2.5 years. United Therapeutics shares traded at $501.92, up 2.94% or $14.32, with a high of $504.07 and low of $479.71. 

Also Read: What Is the S&P 500? A Simple Guide for Everyday Investors

Hyperion DeFi Raises FY2026 Profit Guidance and Announces $20 Million Buyback 

Hyperion DeFi, Inc. (NASDAQ: HYPD) has raised its fiscal 2026 adjusted gross profit guidance to $7 million–$8 million, from the previous $5 million–$7 million range, while announcing a $20 million stock repurchase programme. The company expects adjusted net operating cash flow to turn positive in Q3 2026, ahead of its earlier year-end target. 

For Q3, Hyperion DeFi forecasts adjusted gross profit of $2 million–$2.5 million and operating expenses, excluding stock-based compensation, of $2 million–$2.25 million. It also expects positive core operating earnings, marking the first quarter in which core DeFi business activity is projected to exceed core operating costs. The buyback, authorised by the board, will run for 12 months. Shares traded at $3.59, up 8.79%. 

IonQ Secures $8.18 Million Quantum Security Agreement 

IonQ (NYSE: IONQ) has signed an $8.18 million agreement with Congruity360 to deploy quantum-safe network technology for enterprise data protection. IonQ will provide Clavis quantum key distribution pairs and Solteris Network Appliances, which Congruity360 will integrate into its enterprise data management platform. 

The deployment will support clients across finance, healthcare, insurance, legal services, manufacturing, defence and higher education. The agreement follows a June 2026 White House executive order that moved federal post-quantum security deadlines to 2030 and extended requirements to contractors. IonQ shares rose 10.4% to $43.63, reaching a high of $43.64. 

HCW Biologics Signs Exclusive Distribution Deal for CAR-T Reagent 

HCW Biologics Inc. (NASDAQ: HCWB) has entered an exclusive distribution agreement with Akron Biotech for HCW11-006, a multi-cytokine fusion molecule used in CAR-T cell manufacturing. Akron Biotech will market and distribute the reagent to research institutions and commercial companies within its network, with pre-payment commitments for product sales. 

HCW11-006 combines IL-7, IL-15 and IL-21 to support CAR-T cells enriched in T-memory stem cells. Preclinical studies reported anti-tumour and antiviral activity in experimental HIV-1 and B-cell leukaemia models. HCWB shares traded at $2.505, down 14.80%. 

GoPro Issues $20 Million Convertible Debenture to Yorkville Under $50 Million Programme 

GoPro, Inc. (NASDAQ: GPRO) has entered into a financing agreement to issue a $20 million convertible debenture to Yorkville, marking the third closing under its previously disclosed $50 million financing programme. 

The debenture carries a 3% original issue discount and matures on 26 August 2027. It is convertible at the lower of $1.35 per share or 98% of the lowest five-day volume-weighted average price, subject to a $0.1736 floor and a 4.99% ownership cap. Interest applies only under specified circumstances, including 5% during certain adjustments and 18% upon default or capped conversions. The latest issuance completes the available funding under the programme and is expected to strengthen GoPro’s liquidity and financial flexibility. GoPro shares traded at $1.4455, down 14.97% or $0.2545. 

MMA.INC Details Capital Discipline Plan After $4 Million Equity Investment 

Mixed Martial Arts Group Limited (NYSE American: MMA) has outlined its capital discipline plan following the completion of a US$4 million common equity investment on 20 August 2026. Investors purchased 4 million ordinary shares at US$1 per share, approximately 160% above the company’s closing price on 19 August. 

The transaction involved only common equity, with no warrants, options or convertible securities issued. MMA.INC also stated that no brokerage, placement or investment banking commissions were payable and that it received the full proceeds. Management is reviewing the timing and structure of outstanding obligations, including deferred consideration, to improve working capital. 

As of 31 December 2025, the company reported total assets of A$9.61 million, liabilities of A$6.34 million and a positive net asset position of A$3.26 million. Shares traded at $0.42, down 5.70%. 

Also Read: What Are Fractional Shares?

Focus Universal Announces $3.7 Million Warrant Exercise 

Focus Universal Inc. (NASDAQ: FCUV) announced the exercise of warrants for 279,330 common shares at $13.32 per share, generating $3.72 million in cash proceeds. Following the transaction, shares outstanding will rise to 982,012. 

The company plans to use the net proceeds for continuing product development, working capital and general corporate purposes. Focus Universal shares traded at $6.13, down 63.93%, with a day range of $5.80 to $8.50. 

Overall, the companies delivered mixed but notable developments, with several reporting stronger revenues, earnings, cash flow, acquisitions, strategic partnerships and shareholder returns. However, weaker performance, restructuring pressures, financing needs and market volatility remain evident across others. Collectively, these updates highlight varied corporate growth, investment and capital-allocation strategies. 

Source 

• https://www.nasdaq.com/ 

• spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.dowjones.com/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-industrial-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/sp-500/ 

• https://www.nasdaq.com/market-activity/index/comp 

• https://www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index 

• https://www.spglobal.com/spdji/en/indices/equity/sp-100/ 

• https://www.lseg.com/en/ftse-russell/indices/russell-us 

• https://www.nyse.com/index 

• https://www.nyse.com/index 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-transportation-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-utility-average/ 

• https://www.spglobal.com/spdji/en/indices/equity/dow-jones-composite-average/ 

• https://www.nasdaq.com/market-activity/index/sox 
• https://www.cboe.com/tradable_products/vix/